Shares of Akso Health Group Sponsored ADR (NASDAQ:AHG - Get Free Report) saw unusually-strong trading volume on Monday . Approximately 137,008 shares were traded during trading, an increase of 157% from the previous session's volume of 53,366 shares.The stock last traded at $2.3660 and had previously closed at $2.36.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Akso Health Group in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Akso Health Group currently has a consensus rating of "Sell".
View Our Latest Stock Report on Akso Health Group
Akso Health Group Trading Down 2.5%
The company has a fifty day moving average of $1.67 and a 200-day moving average of $1.61.
Institutional Trading of Akso Health Group
An institutional investor recently bought a new position in Akso Health Group stock. SmartHarvest Portfolios LLC purchased a new stake in shares of Akso Health Group Sponsored ADR (NASDAQ:AHG - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 16,748 shares of the company's stock, valued at approximately $27,000. Institutional investors own 1.21% of the company's stock.
Akso Health Group Company Profile
(
Get Free Report)
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Akso Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Akso Health Group wasn't on the list.
While Akso Health Group currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.